4.6 Review

Long non-coding RNA PVT1: A promising chemotherapy and radiotherapy sensitizer

Related references

Note: Only part of the references are listed.
Review Medicine, Research & Experimental

Traditional Chinese medicine for precancerous lesions of gastric cancer: A review

Weichao Xu et al.

Summary: The article discusses the treatment of gastric precancerous lesions (PLGC) stage, proving the effectiveness of traditional Chinese medicine in treating and preventing such diseases.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Oncology

Long non-coding RNA PVT1 facilitates cell migration and invasion by regulating miR-148a-3p and ROCK1 in breast cancer

H. L. Li et al.

Summary: The study demonstrated that PVT1 was upregulated and promoted cell migration and invasion in breast cancer by regulating miR-148a-3p and ROCK1. This suggests that PVT1 may serve as a potential biomarker for the diagnosis and treatment of breast cancer.

CLINICAL & TRANSLATIONAL ONCOLOGY (2022)

Article Oncology

Targeting long non-coding RNA PVT1/TGF-β/Smad by p53 prevents glioma progression

Zhang Li et al.

Summary: This study discovered that p53 exerts anti-oncogenic function on glioma development by suppressing IncRNA PVT1 and subsequently inactivating TGF-beta/Smad pathway.

CANCER BIOLOGY & THERAPY (2022)

Article Environmental Sciences

LncRNA PVT1 contributes to invasion and doxorubicin resistance of bladder cancer cells through promoting MDM2 expression and AURKB-mediated p53 ubiquitination

Xiaoqin Jiang et al.

Summary: This study found that lncRNA PVT1 promotes proliferation and drug resistance of bladder cancer cells by upregulating MDM2 expression and AURKB-mediated p53 ubiquitination.

ENVIRONMENTAL TOXICOLOGY (2022)

Review Medicine, General & Internal

Cell Signaling Pathways That Promote Radioresistance of Cancer Cells

Michel M. Ouellette et al.

Summary: Radiation therapy is a common treatment for solid tumors, but radioresistance limits its effectiveness in many cancer patients. Radiation eradicates cancer cells by causing DNA damage, but it also activates multiple prosurvival signaling pathways that protect cancer cells. Targeting these pathways may improve the sensitivity of cancer cells to radiation.

DIAGNOSTICS (2022)

Article Cell Biology

Hypoxia-induced PVT1 promotes lung cancer chemoresistance to cisplatin by autophagy via PVT1/miR-140-3p/ATG5 axis

Jiying Wang et al.

Summary: Lung cancer chemoresistance during chemotherapy is a challenge, with hypoxia being one of the contributing factors. This study aimed to analyze the regulatory relationship between hypoxia and PVT1 and the mechanism of PVT1 in hypoxia-induced chemoresistance in lung cancer. The results showed that the expression of PVT1 is regulated by HIF-1 alpha and participates in hypoxia-induced chemoresistance.

CELL DEATH DISCOVERY (2022)

Article Oncology

Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer

Wangkai Xie et al.

Summary: Pancreatic cancer is a leading cause of cancer death worldwide due to its lack of early symptoms, metastasis, and chemoresistance. This review article summarizes the role of long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs) in modulating chemosensitivity in pancreatic cancer cells. It also highlights the potential compounds that can modulate the expression of lncRNAs and enhance chemosensitivity in pancreatic cancers.

SEMINARS IN CANCER BIOLOGY (2022)

Review Immunology

A systematic review of asymptomatic infections with COVID-19

Zhiru Gao et al.

Summary: Since the outbreak of COVID-19 at the end of December 2019, it has caused significant harm and challenges to over 200 countries and regions worldwide. Many patients with COVID-19 are asymptomatic or have only mild symptoms, yet they can still spread the virus, making screening for asymptomatic infections difficult and complicating national prevention and control efforts.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2021)

Article Biochemistry & Molecular Biology

UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance

Yumei Huang et al.

Summary: The study reveals the important role of UBE2O in radioresistance of lung cancer by promoting Mxi1 ubiquitination and degradation, facilitating tumor progression. Additionally, UBE2O is found to be overexpressed and negatively correlated with Mxi1 protein levels in lung cancer tissues.

CELL DEATH AND DIFFERENTIATION (2021)

Review Cell Biology

Pioneer of prostate cancer: past, present and the future ofFOXA1

Mona Teng et al.

Summary: Prostate cancer, the most commonly diagnosed non-cutaneous cancer in North American men, is often treated with androgen deprivation therapy. However, resistance can develop, leading to lethal disease. FOXA1, a pioneer factor that helps shape and regulate androgen receptor signaling, plays a crucial role in prostate cancer development and progression. Mutations in FOXA1 can result in functional alterations, and post-translational modifications can also modulate its activity in prostate cancer. Identifying the function and regulation of FOXA1 in prostate cancer is important for guiding future clinical interventions.

PROTEIN & CELL (2021)

Review Biochemistry & Molecular Biology

Molecular Mechanisms of Treatment Resistance in Glioblastoma

Alexander Ou et al.

Summary: Glioblastoma is the most common malignant primary brain tumor in adults and is almost invariably fatal. The challenges of treating glioblastoma include the blood-brain barrier, tumoral heterogeneity, and immunosuppressive microenvironment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Cell Biology

LncRNA linc00312 suppresses radiotherapy resistance by targeting DNA-PKcs and impairing DNA damage repair in nasopharyngeal carcinoma

Zhen Guo et al.

Summary: Our study found that linc00312 is significantly down-regulated in NPC tissues and higher expression of linc00312 is associated with longer overall survival and better short-term radiotherapy efficacy. Overexpression of linc00312 increases NPC cells' sensitivity to ionizing radiation by hindering the DNA repair and cell cycle control mechanisms. DNA-PKcs was identified as the binding protein of linc00312, revealing a novel mechanism in the DNA damage response.

CELL DEATH & DISEASE (2021)

Article Oncology

Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs

Chenglong Chen et al.

Summary: Immunotherapy has shown promising efficacy in treating osteosarcoma, especially for metastatic or recurrent cases. Recent advancements in biomarker development have increased the number of patients benefiting from immunotherapies, offering hope to patients in need of new treatments.

CANCER LETTERS (2021)

Article Cell Biology

Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/EZH2 complex in pancreatic cancer

Yan Sun et al.

Summary: The poor prognosis of pancreatic cancer is mainly due to resistance to therapies, including gemcitabine. Long noncoding RNA PVT1 (lncRNA PVT1) interacts with enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2), promoting gemcitabine resistance. Histone acetyltransferase 1 (HAT1) enhances pancreatic cancer cells' tolerance to gemcitabine, with mechanisms regulated by PVT1 and EZH2.

CELL DEATH & DISEASE (2021)

Review Oncology

Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing

Alexander E. Kabakov et al.

Summary: Certain cancer cells become more resistant to radiation under hypoxic conditions, decreasing the efficacy of radiotherapy for hypoxic tumors. Understanding the mechanisms by which cancer cells adapt to hypoxia can help improve the sensitivity of hypoxic tumors to radiotherapy.

CANCERS (2021)

Article Cell Biology

Interplay between SARS-CoV-2 and human long non-coding RNAs

Maryam Moazzam-Jazi et al.

Summary: This study identified potential roles of lncRNAs in inflammation development during SARS-CoV-2 infection, highlighted the major regulatory role of certain lncRNAs and their interactions with the SARS-CoV-2 genome. Importantly, mRNA-based vaccines are not expected to have side effects due to interactions with human lncRNAs.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Review Biochemistry & Molecular Biology

Pathogenesis and therapeutic strategy in platinum resistance lung cancer

Panpan Lv et al.

Summary: Platinum resistance is a challenge in lung cancer treatment, and understanding its molecular mechanisms, identifying predictive markers, and developing more effective and less toxic agents are crucial. Addressing this issue could lead to the development of improved treatment for refractory lung cancer in the future.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Article Immunology

Atezolizumab and blockade of LncRNA PVT1 attenuate cisplatin resistant ovarian cancer cells progression synergistically via JAK2/STAT3/PD-L1 pathway

Ying Chen et al.

Summary: The study found that the expressions of PVT1 and PD-L1 were significantly higher in cisplatin resistant epithelial ovarian cancer, and there was a positive correlation between them, with higher expressions associated with more malignant clinical behavior and shorter survival period.

CLINICAL IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

Tumor microenvironment and radioresistance

Tatsuya Suwa et al.

Summary: Metastasis of cancer cells relies on the suitable microenvironment. The complex cellular society and diverse oxygen and nutrient supply in tumor tissue affect the characteristics of cancer cells and their resistance to radiation. Understanding tumor microenvironments and their influence on cancer behavior is crucial for developing novel therapeutic strategies.

EXPERIMENTAL AND MOLECULAR MEDICINE (2021)

Article Otorhinolaryngology

lncRNA PVT1 promotes cetuximab resistance of head and neck squamous cell carcinoma cells by inhibiting miR-124-3p

Shuo Yang et al.

Summary: The study revealed that lncRNA PVT1 decreases the sensitivity of HNSCC cells to cetuximab by enhancing methylation-mediated inhibition of miR-124-3p, providing a new insight into the cetuximab chemoresistance of HNSCC.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2021)

Article Cell Biology

Exosomal lncRNA PVT1/VEGFA Axis Promotes Colon Cancer Metastasis and Stemness by Downregulation of Tumor Suppressor miR-152-3p

Shiue-Wei Lai et al.

Summary: Exosomal PVT1 promotes colon cancer metastasis through its association with EGFR and VEGFA expression. miR-152-3p targets both PVT1 and VEGFA, and this regulatory pathway can be explored for drug development and as a prognostic biomarker.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Article Cell Biology

A positive feedback regulatory loop involving the lncRNA PVT1 and HIF-1α in pancreatic cancer

Yiping Zhu et al.

Summary: The reciprocal regulation between PVT1 and HIF-1α in pancreatic cancer forms a positive feedback loop, which could be a potential therapeutic target for the treatment of PC.

JOURNAL OF MOLECULAR CELL BIOLOGY (2021)

Article Oncology

Key radioresistance regulation models and marker genes identified by integrated transcriptome analysis in nasopharyngeal carcinoma

Zhuang Sun et al.

Summary: This study identified 1182 differentially expressed genes between radioresistant and radiosensitive NPC tissue samples, with 22 genes upregulated and 1160 genes downregulated in the radioresistant group. Integration analysis revealed 10 major NPC radiation resistance network models, with three core genes DOCK4, MCM9, and POPDC3 identified among 12 common downregulated genes. Further experimental studies on these core genes are warranted to deepen the understanding of NPC radioresistance mechanisms.

CANCER MEDICINE (2021)

Review Cell Biology

The Role of the Hedgehog Pathway in Chemoresistance of Gastrointestinal Cancers

Yabing Liang et al.

Summary: This review focuses on the recent advances in the roles of the hedgehog pathway in drug resistance of gastrointestinal cancers and the novel drugs and strategies targeting hedgehog signaling.

CELLS (2021)

Article Medicine, Research & Experimental

Long Noncoding RNA PVT1 Promotes Stemness and Temozolomide Resistance through miR-365/ELF4/SOX2 Axis in Glioma

Rui Gong et al.

Summary: This study identified that PVT1 promoted glioma stemness through the miR-365/ELF4/SOX2 axis.

EXPERIMENTAL NEUROBIOLOGY (2021)

Article Oncology

LncRNA-PVT1 indicates a poor prognosis and promotes angiogenesis via activating the HNF1B/EMT axis in glioma

Yongyan Bi et al.

Summary: Recent studies have shown that lncRNA-PVT1 is significantly upregulated in glioma tissues and plays an important role in cell proliferation, migration, invasion, and angiogenesis. Up-regulation of lncRNA-PVT1 promotes glioma progression both in vitro and in vivo by regulating miR-1207-3p expression. Prediction software was used to identify the regulatory mechanisms of lncRNA-PVT1, miR-1207-3p, and HNF1B, which were validated using a dual-luciferase reporter gene system. This suggests that the lncRNA-PVT1/miR-1207-3p/HNF1B axis may serve as novel molecular targets for glioma prevention and treatment.

JOURNAL OF CANCER (2021)

Article Biochemistry & Molecular Biology

USP24-GSDMB complex promotes bladder cancer proliferation via activation of the STAT3 pathway

Haiqing He et al.

Summary: The study demonstrated that GSDMB promotes bladder cancer progression and interacts with STAT3 to activate signaling pathways in tumor cells. Moreover, USP24 stabilizes GSDMB to activate STAT3 signaling in bladder cancer cells.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Review Medicine, Research & Experimental

Recent progress in nanomedicine for enhanced cancer chemotherapy

Guoqing Wei et al.

Summary: Nanomedicine has shown significant progress in improving cancer chemotherapy, including drug enrichment and tissue penetration, subcellular organelle-targeted chemotherapy, and reversal of multidrug resistance. The advantages of combination therapy in cancer treatment are emphasized.

THERANOSTICS (2021)

Article Oncology

PVT1 Expression Is a Predictor for Poor Survival of Prostate Cancer Patients

Jianhua Liu et al.

Summary: The study investigated the expression of PVT1 in prostate cancer and found significant correlations with tumor-related characteristics, suggesting that PVT1 may serve as a biomarker for the diagnosis and prognosis of prostate cancer.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2021)

Review Cell Biology

Long noncoding RNA PVT1: A highly dysregulated gene in malignancy

Soudeh Ghafouri-Fard et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2020)

Review Oncology

Organoid of ovarian cancer: genomic analysis and drug screening

H-D Liu et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2020)

Review Biochemistry & Molecular Biology

Role of non-coding RNAs and RNA modifiers in cancer therapy resistance

Xinyi Zhang et al.

MOLECULAR CANCER (2020)

Review Oncology

PVT1 Long Non-coding RNA in Gastrointestinal Cancer

Agueda Martinez-Barriocanal et al.

FRONTIERS IN ONCOLOGY (2020)

Review Oncology

Oncogenic Role of PVT1 and Therapeutic Implications

Onayemi Titilayo Onagoruwa et al.

FRONTIERS IN ONCOLOGY (2020)

Article Biotechnology & Applied Microbiology

Tissue-based long non-coding RNAs PVT1, TUG1 and MEG3 signature predicts Cisplatin resistance in ovarian Cancer

Nashwa El-Khazragy et al.

GENOMICS (2020)

Article Medicine, Research & Experimental

lncRNA PVT1 Promotes Tumorigenesis of Colorectal Cancer by Stabilizing miR-16-5p and Interacting with the VEGFA/VEGFR1/AKT Axis

Hailu Wu et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2020)

Review Cell Biology

CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer

Maria Auxiliadora Olivares-Urbano et al.

CELLS (2020)

Article Medicine, Research & Experimental

MGMT expression affects the gemcitabine resistance of pancreatic cancer cells

Yu Shi et al.

LIFE SCIENCES (2020)

Review Biochemistry & Molecular Biology

The c-MET oncoprotein: Function, mechanisms of degradation and its targeting by novel anti-cancer agents

Kyung Chan Park et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2020)

Review Respiratory System

Radiotherapy treatment for lung cancer: Current status and future directions

Shalini K. Vinod et al.

RESPIROLOGY (2020)

Editorial Material Oncology

Editorial: PVT1 in Cancer

Olorunseun O. Ogunwobi et al.

FRONTIERS IN ONCOLOGY (2020)

Article Oncology

Multidrug Resistance of Gastric Cancer: The Mechanisms and Chinese Medicine Reversal Agents

Wen-Jie Huang et al.

CANCER MANAGEMENT AND RESEARCH (2020)

Article Integrative & Complementary Medicine

Ginkgolide B inhibits lung cancer cells promotion via beclin-1-dependent autophagy

Xuan Wang et al.

BMC COMPLEMENTARY MEDICINE AND THERAPIES (2020)

Article Medicine, General & Internal

Radiotherapy toxicity

Dirk De Ruysscher et al.

NATURE REVIEWS DISEASE PRIMERS (2019)

Review Radiology, Nuclear Medicine & Medical Imaging

Future of Radiotherapy in Nasopharyngeal Carcinoma

Xue-Song Sun et al.

BRITISH JOURNAL OF RADIOLOGY (2019)

Review Biochemistry & Molecular Biology

Long non-coding RNA PVT1 interacts with MYC and its downstream molecules to synergistically promote tumorigenesis

Ke Jin et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2019)

Review Oncology

PVT1 Signaling Is a Mediator of Cancer Progression

Camille Derderian et al.

FRONTIERS IN ONCOLOGY (2019)

Review Oncology

PVT1 Promotes Cancer Progression via MicroRNAs

Wenxi Wang et al.

FRONTIERS IN ONCOLOGY (2019)

Review Oncology

Chemoresistance Mediated by ceRNA Networks Associated With the PVT1 Locus

Olorunseun O. Ogunwobi et al.

FRONTIERS IN ONCOLOGY (2019)

Review Oncology

Long Non-coding RNA PVT1 as a Prognostic and Therapeutic Target in Pediatric Cancer

Ariadna Boloix et al.

FRONTIERS IN ONCOLOGY (2019)

Article Biochemistry & Molecular Biology

Long noncoding RNA PVT1 promotes laryngeal squamous cell carcinoma development by acting as a molecular sponge to regulate miR-519d-3p

Xiling Zheng et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

Article Cell Biology

LncRNA PVT1 regulates growth, migration, and invasion of bladder cancer by miR-31/CDK1

Zhaoju Tian et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Review Oncology

Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors

Prashanth Rawla et al.

WORLD JOURNAL OF ONCOLOGY (2019)

Review Oncology

Current and future therapeutic approaches for osteosarcoma

Douglas J. Harrison et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2018)

Article Chemistry, Medicinal

Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment

Deepali Waghray et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Medicine, Research & Experimental

Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer

Qi Yang et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Review Chemistry, Medicinal

Cetuximab and the Head and Neck Squamous Cell Cancer

Riccardo Concu et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)

Article Biochemistry & Molecular Biology

LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer

Jing Zhao et al.

ONCOGENE (2018)

Review Biochemistry & Molecular Biology

Hedgehog Signaling Pathway and Autophagy in Cancer

Xian Zeng et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Biochemistry & Molecular Biology

A novel HIF-1α/VMP1-autophagic pathway induces resistance to photodynamic therapy in colon cancer cells

M. E. Rodriguez et al.

PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2017)

Article Medicine, Research & Experimental

Kanglaite inhibits the expression of drug resistance genes through suppressing PVT1 in cisplatin-resistant gastric cancer cells

Xian-Wen Zhang et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)

Review Oncology

The molecular mechanisms of chemoresistance in cancers

Hua-Chuan Zheng

ONCOTARGET (2017)

Article Cell Biology

Knockdown of Lncrna PVT1 Enhances Radiosensitivity in Non-Small Cell Lung Cancer by Sponging Mir-195

Dapeng Wu et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)

Article Biochemistry & Molecular Biology

Long non-coding RNA PVT1 promotes glycolysis and tumor progression by regulating miR-497/HK2 axis in osteosarcoma

Jingyi Song et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Article Medicine, General & Internal

Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment

Shanthi Marur et al.

MAYO CLINIC PROCEEDINGS (2016)

Article Gastroenterology & Hepatology

Advanced gastric cancer: Current treatment landscape and future perspectives

Antonia Digklia et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2016)

Article Biochemistry & Molecular Biology

Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance

Xian-wen Zhang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Review Oncology

A Review of the Evolution of Systemic Chemotherapy in the Management of Colorectal Cancer

Bengt Gustavsson et al.

CLINICAL COLORECTAL CANCER (2015)

Article Oncology

Evidence-based Estimates of the Demand for Radiotherapy

G. P. Delaney et al.

CLINICAL ONCOLOGY (2015)

Review Pharmacology & Pharmacy

Gemcitabine resistance in pancreatic ductal adenocarcinoma

Yoav Binenbaum et al.

DRUG RESISTANCE UPDATES (2015)

Article Biochemistry & Molecular Biology

CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features

Rania Elakoum et al.

BIOCHIMIE (2014)

Article Multidisciplinary Sciences

PVT1 dependence in cancer with MYC copy-number increase

Yuen-Yi Tseng et al.

NATURE (2014)

Article Cell Biology

Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis

Matthew Brentnall et al.

BMC CELL BIOLOGY (2013)

Review Otorhinolaryngology

Targeting tumor hypoxia in nasopharyngeal carcinoma

Bo Hong et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2013)

Article Biochemistry & Molecular Biology

Inhibition of c-Met activation sensitizes osteosarcoma cells to cisplatin via suppression of the PI3K-Akt signaling

Kelai Wang et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)

Article Cell & Tissue Engineering

MEF Promotes Stemness in the Pathogenesis of Gliomas

Elena Bazzoli et al.

CELL STEM CELL (2012)

Review Medicine, General & Internal

Cancer and Radiation Therapy: Current Advances and Future Directions

Rajamanickam Baskar et al.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2012)

Article Biochemistry & Molecular Biology

Radiation-induced double-strand breaks require ATM but not Artemis for homologous recombination during S-phase

Sabrina Koecher et al.

NUCLEIC ACIDS RESEARCH (2012)

Article Biochemistry & Molecular Biology

Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells

Lei You et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)

Article Multidisciplinary Sciences

Integrated genomic analyses of ovarian carcinoma

D. Bell et al.

NATURE (2011)

Article Oncology

Osteosarcoma

J. Ritter et al.

ANNALS OF ONCOLOGY (2010)

Review Oncology

Role of cancer stem cells in pancreatic ductal adenocarcinoma

Gregory Sergeant et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2009)

Review Genetics & Heredity

Long non-coding RNAs: insights into functions

Tim R. Mercer et al.

NATURE REVIEWS GENETICS (2009)

Article Virology

Pvt1-encoded microRNAs in oncogenesis

Gabriele B. Beck-Engeser et al.

RETROVIROLOGY (2008)

Review Cell Biology

The Gli code: an information nexus regulating cell fate, stemness and cancer

Ariel Ruiz i Altaba et al.

TRENDS IN CELL BIOLOGY (2007)